BRIACELL THERAPEUTICS CORP (BCT.CA) Stock Earnings & Estimates
Canada - Toronto Stock Exchange - TSX:BCT - CA1079303071 - Common Stock
15.8 CAD
-1.34 (-7.82%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 380.95% | N/A | N/A | |||||||||||||
| EBITDA YoY % growth | -470K | N/A | -1.688M | -2.344M -38.90% | -3.613M -54.12% | -4.519M -25.08% | -3.547M 21.50% | -6.961M -96.22% | -15.274M -119.43% | -23.257M -52.27% | -33.246M -42.95% | -27.098M 18.49% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -470K | -3.548M -654.98% | -1.689M 52.41% | -2.345M -38.83% | -3.625M -54.63% | -4.533M -25.04% | -3.561M 21.44% | -6.976M -95.89% | -15.289M -119.16% | -23.272M -52.22% | -33.33M -43.22% | -27.205M 18.38% | N/A -25.11% | N/A -27.89% | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -195.00 -26.19% | -45.00 76.92% | -128.19 -184.87% | N/A 90.98% | N/A 70.31% | N/A 54.12% | N/A 52.56% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -3.31 89.96% | -4.89 79.02% | -2.77 83.13% |
| Revenue Q2Q % growth | 2.121M | ||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.757M -11.79% | -8.585M -19.75% | -9.393M -48.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -55.49 -428.48% | -12.23 | -43.26 | -353.68% |
| Q3 2025 Q2Q % growth | -16.40 -199.39% | -17.78 | 1.38 | 7.74% |
| Q2 2025 Q2Q % growth | -23.30 78.12% | -19.59 | -3.71 | -18.91% |
| Q1 2025 Q2Q % growth | -33.00 -159.46% | -12.12 | -20.88 | -172.28% |
| Q4 2024 Q2Q % growth | -10.50 50.00% | -78.78 | 68.28 | 86.67% |
| Q3 2024 Q2Q % growth | 16.50 134.38% | -83.33 | 99.83 | 119.80% |
| Q2 2024 Q2Q % growth | -106.50 7.79% | -30.30 | -76.20 | -251.49% |
| Q1 2024 Q2Q % growth | 55.50 628.57% | -27.27 | 82.77 | 303.52% |
| Q4 2023 Q2Q % growth | -21.00 86.27% | -60.60 | 39.60 | 65.35% |
| Q3 2023 Q2Q % growth | -48.00 | -53.78 | 5.78 | 10.75% |
| Q2 2023 Q2Q % growth | -115.50 -220.83% | -53.78 | -61.72 | -114.75% |
| Q1 2023 Q2Q % growth | -10.50 | -50.00 | 39.50 | 79.00% |
| Q4 2022 Q2Q % growth | -153.00 | -46.21 | -106.79 | -231.12% |
| Q3 2022 Q2Q % growth | -48.00 | -28.79 | -19.22 | -66.75% |
| Q2 2022 Q2Q % growth | -36.00 | -25.00 | -11.00 | -44.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | N/A | 0% | -546.89% |
| Revenue | 0% | N/A | 0% | N/A |